Search
for
Sort by
Research 511–540 of 1000+
- Hypopigmented Mycosis Fungoides Treated with 308 nm Excimer Laser
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Local Corticosteroids for Alopecia Areata: A Narrative Review
- Humanized CXCL12 antibody delays onset and modulates immune response in alopecia areata mice: insights from single-cell RNA sequencing
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Drug eruptions in dermatology
- Immunomodulators in the treatment of cutaneous lymphoma
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
- Twenty-Nail Dystrophy Treated with Hydroxychloroquine in a Patient with Alopecia Areata
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- 174 Dermis-hair follicle communication: Extracellular microvesicles signaling for hair regeneration
- Alopecia Areata in 12 years old female treated with Oral Azathioprine: A case report and review
- Micro-Injury Induces Hair Regeneration and Vitiligo Repigmentation Through Wnt/ β-Catenin Pathway
- TOXIC EPIDERMAL NECROLYSIS
- The Basic Science of Hair Biology
- Immune cell regulation of the hair cycle
- The Negative Regulator CXXC5: Making WNT Look a Little Less Dishevelled
- Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Insights into the context-dependent immunological roles of the CXCL12–CXCR4 axis in alopecia
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Cutaneous signals of immune system disease
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Tofacitinib for the treatment of lichen planopilaris: A case series